Henan Taloph Pharmaceutical StockLtd Balance Sheet Health
Financial Health criteria checks 4/6
Henan Taloph Pharmaceutical StockLtd has a total shareholder equity of CN¥1.6B and total debt of CN¥911.8M, which brings its debt-to-equity ratio to 56.3%. Its total assets and total liabilities are CN¥3.7B and CN¥2.1B respectively. Henan Taloph Pharmaceutical StockLtd's EBIT is CN¥106.5M making its interest coverage ratio 2. It has cash and short-term investments of CN¥397.8M.
Key information
56.3%
Debt to equity ratio
CN¥911.84m
Debt
Interest coverage ratio | 2x |
Cash | CN¥397.75m |
Equity | CN¥1.62b |
Total liabilities | CN¥2.10b |
Total assets | CN¥3.72b |
Recent financial health updates
No updates
Recent updates
The Market Doesn't Like What It Sees From Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) Revenues Yet
Sep 27Henan Taloph Pharmaceutical StockLtd (SHSE:600222) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 06Henan Taloph Pharmaceutical Stock Co.,Ltd (SHSE:600222) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Mar 08Financial Position Analysis
Short Term Liabilities: 600222's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥2.0B).
Long Term Liabilities: 600222's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥102.7M).
Debt to Equity History and Analysis
Debt Level: 600222's net debt to equity ratio (31.7%) is considered satisfactory.
Reducing Debt: 600222's debt to equity ratio has reduced from 83.7% to 56.3% over the past 5 years.
Debt Coverage: 600222's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 600222's interest payments on its debt are not well covered by EBIT (2x coverage).